Pharmaceutical Technology® Europe Presents Educational Webcast Addressing Concerns Around Titanium Dioxide (TIO2)
July 8, 2019The webcast will feature expert insights from industry leaders
CRANBURY, N.J.–(BUSINESS WIRE)–#pharma—Pharmaceutical Technology® Europe, a comprehensive multimedia platform for professionals in the global pharmaceutical manufacturing drug development community, will host a webcast titled “Science or Hype? Navigating the Questions about Titanium Dioxide Safety” on Thursday, July 11 at 10 a.m. EDT.
“In this webcast, our industry experts will discuss the current status and assess the potential market impact for the pharmaceutical industry,” said Tom Ehardt, president of MultiMedia Healthcare, LLC. “As questions are rising about the use of TiO2, our webcast will inform and educate scientists and pharma professionals about its use in foods, additives and pharmaceutical products.”
Presenters for this webcast are as follows:
- David R. Schoneker, M.S., global regulatory director – strategic relationships of Colorcon Limited, US;
- Jason Teckoe, Ph.D., M.Sc., technical director (Europe, Middle East, Africa) of Colorcon Limited, UK;
- Kevin Hughes, B.Sc. (Hons), quality assurance and regulatory affairs manager (Europe, Middle East, Africa) of Colorcon Limited, UK;
- Rita Peters, editor in chief of Pharmaceutical Technology®, will be the moderator.
This webcast will provide attendees with a clear understanding of the situation relating to the use of TiO2, based on facts and science. The discussion will review the current legal situation and the position of the different regulatory bodies. Participants will learn about the science-based facts influencing the industry response and gain insight into the possible implications on the use of TiO2 in pharmaceutical products, as well as food supplements.
For more information and to register, click here.
About Pharmaceutical Technology®
Pharmaceutical Technology® is a multimedia platform that provides professionals in the global pharmaceutical manufacturing drug development community with dynamic and reliable cutting-edge, peer-reviewed content and features on next-generation process development and manufacturing, formulation, drug delivery, ingredients, regulation, analytics, packaging, supply chain and outsourcing. Pharmaceutical Technology® also provides comprehensive coverage of international regulations and business trends related to drug development. Pharmaceutical Technology® is part of MultiMedia Healthcare, LLC.
Contacts
Pharmaceutical Technology® Media Contacts
Theresa Burek, 609-250-4331
[email protected]
Michelle Wood, 609-716-7777
[email protected]
Pharmaceutical Technology® Europe Presents Educational Webcast Addressing Concerns Around Titanium Dioxide (TIO2)
July 8, 2019The webcast will feature expert insights from industry leaders
CRANBURY, N.J.–(BUSINESS WIRE)–#pharma—Pharmaceutical Technology® Europe, a comprehensive multimedia platform for professionals in the global pharmaceutical manufacturing drug development community, will host a webcast titled “Science or Hype? Navigating the Questions about Titanium Dioxide Safety” on Thursday, July 11 at 10 a.m. EDT.
“In this webcast, our industry experts will discuss the current status and assess the potential market impact for the pharmaceutical industry,” said Tom Ehardt, president of MultiMedia Healthcare, LLC. “As questions are rising about the use of TiO2, our webcast will inform and educate scientists and pharma professionals about its use in foods, additives and pharmaceutical products.”
Presenters for this webcast are as follows:
- David R. Schoneker, M.S., global regulatory director – strategic relationships of Colorcon Limited, US;
- Jason Teckoe, Ph.D., M.Sc., technical director (Europe, Middle East, Africa) of Colorcon Limited, UK;
- Kevin Hughes, B.Sc. (Hons), quality assurance and regulatory affairs manager (Europe, Middle East, Africa) of Colorcon Limited, UK;
- Rita Peters, editor in chief of Pharmaceutical Technology®, will be the moderator.
This webcast will provide attendees with a clear understanding of the situation relating to the use of TiO2, based on facts and science. The discussion will review the current legal situation and the position of the different regulatory bodies. Participants will learn about the science-based facts influencing the industry response and gain insight into the possible implications on the use of TiO2 in pharmaceutical products, as well as food supplements.
For more information and to register, click here.
About Pharmaceutical Technology®
Pharmaceutical Technology® is a multimedia platform that provides professionals in the global pharmaceutical manufacturing drug development community with dynamic and reliable cutting-edge, peer-reviewed content and features on next-generation process development and manufacturing, formulation, drug delivery, ingredients, regulation, analytics, packaging, supply chain and outsourcing. Pharmaceutical Technology® also provides comprehensive coverage of international regulations and business trends related to drug development. Pharmaceutical Technology® is part of MultiMedia Healthcare, LLC.
Contacts
Pharmaceutical Technology® Media Contacts
Theresa Burek, 609-250-4331
[email protected]
Michelle Wood, 609-716-7777
[email protected]